Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation
Guanyu Li,1,2 Tong Wang,1,2 Xiaoyi Zhang,1,2 Shurui Zhao,1,2 Yaonan Wang,1,2 Jianhui Wu,1,2 Shiqi Peng,1,2 Ming Zhao1– 3 1Beijing Area Major Laboratory of Peptide and Small Molecular Drugs, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Capital Medical University, Be...
Saved in:
Main Authors: | Li G (Author), Wang T (Author), Zhang X (Author), Zhao S (Author), Wang Y (Author), Wu J (Author), Peng S (Author), Zhao M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual Sensitization Anti-Resistant Nanoparticles for Treating Refractory Breast Cancers via Apoptosis-Inducing
by: Ju R, et al.
Published: (2023) -
Synthesis, mechanism of action, and structure-activity relationships of 1,3-oxazolidinones as anti-bacterial Agent: A review
by: Ali Hantosh, et al.
Published: (2022) -
Impact of the Number of Anti-Thrombosis Agents in Hemodialysis Patients: BOREAS-HD2 Study
by: Marenao Tanaka, et al.
Published: (2017) -
Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent
by: Vijay Laxmi Trivedi, et al.
Published: (2023) -
Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease
by: Yusaku Matsuda, et al.
Published: (2019)